Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the year ending March 31, 2022. For the year, the company expects net sales of JPY 8,400 million, operating profit of JPY 1,100 million, profit of JPY 770 million and earnings per share of JPY 26.80.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
550 JPY | -1.61% | -0.54% | +7.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.21% | 104M | |
+73.40% | 12.42B | |
-19.26% | 7.94B | |
+1.44% | 6.17B | |
+13.65% | 5.5B | |
+40.00% | 5.01B | |
-15.25% | 4.88B | |
-16.42% | 4.2B | |
-27.56% | 2.73B | |
+47.06% | 2.27B |
- Stock Market
- Equities
- 7775 Stock
- News Daiken Medical Co., Ltd.
- Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2022